Phase 2 trial of NOV-002 [glutathione/cisplatin] with carboplatin in women with recurrent and platinum- resistant tumors of Mullerian origin,

Trial Profile

Phase 2 trial of NOV-002 [glutathione/cisplatin] with carboplatin in women with recurrent and platinum- resistant tumors of Mullerian origin,

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Mar 2015

At a glance

  • Drugs Glutathione/cisplatin (Primary) ; Carboplatin
  • Indications Ovarian cancer
  • Focus Therapeutic Use
  • Sponsors Cellectar Biosciences
  • Most Recent Events

    • 11 Feb 2014 Novelos Therapeutics now known as Cellectar Biosciences
    • 08 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jun 2008 Interim results presented at the 2008 annual meeting of the American Society of Clinical Oncology (ASCO).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top